Michael Friebe

Michael Friebe is the founder of Neuromed AG, which was founded in 1993.
He is currently the Deputy Chairman-Advisory Board at SurgicEye GmbH, Co-Managing Director at m2f investment Ltd., Managing Director at IDTM GmbH, and Managing Director at FRIIH GmbH since 2014.
He also serves as the President at UMS-Neuromed since 2009.
In his former positions, he was the President & Chief Executive Officer at TomoVation GmbH, Chairman-Supervisory Board at PPA Technologies AG, Director at Safeplus International Holdings Ltd. from 2005 to 2006, Director at IntraOp Medical Corp.
from 2004 to 2009, and Non-Executive Director at Eckert & Ziegler BEBIG SA in 2012.
Dr. Friebe holds a graduate degree from Golden Gate University, undergraduate and graduate degrees from Universität Stuttgart, and a doctorate degree from the University of Witten.